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Introduction
Arsenic is a widely distributed  semimetallic 
element that occurs naturally in various com-
pounds in the crust of the earth. Approximately 
160 million people worldwide are exposed to 
unsafe high levels of arsenic in drinking water 
(Hubaux et al. 2013). In particular, about 
25 million people in Bangladesh and 6 mil-
lion in India are chronically exposed to a very 
high level of arsenic exceeding 50 μg/L via 
ground water (Rahman et al. 2001), which is 
significantly greater than the current maximum 
contaminant level (MCL) of 10 μg/L set forth 
by the U.S. Environmental Protection Agency 
(2014). Long-term arsenic exposure leads to an 
increased risk of skin, bladder, and liver cancers 
and, especially, lung cancer. Epidemiological 
investigations and laboratory studies have pro-
vided evidence that ingestion of arsenic via 
drinking water or inhalation of air increases 
the risk of lung cancer in a dose–dependent 
way (Boffetta 2004; Chen et al. 2004). 
However, the exact mechanism of arsenic-
induced cell malignant transformation and 
cancer  development remains to be investigated.
Current proposed mechanisms underlying 
arsenic carcinogenesis include arsenic-induced 
genetic changes and epigenetic alterations 
(Hubaux et al. 2013). The epigenetic altera-
tions consist of histone modification, DNA 
methylation, and microRNA (miRNA) 
regulation. We and others (Beezhold et al. 
2011; He et al. 2013b; Wang et al. 2011) have 
observed aberrant miRNA expression profiles 
after heavy-metal exposure in various cell types, 
which indicates the involvement of miRNAs 
in environmental carcinogenesis. However, 
it remains to be determined whether these 
 miRNAs play causal roles in arsenic-induced 
tumor initiation and development.
Angiogenesis is the formation of new 
blood vessels from existing vasculatures to 
induce tumor growth. Outside of its role 
in physiological processes such as embryo 
develop ment and wound healing, angio-
genesis is required for cancer development. 
Angiogenesis is critical for a tumor colony to 
grow and become invasive (D’Amico 2004). 
In the present study, we aimed to determine 
a) the roles of miRNAs in arsenic-induced 
tumor angiogenesis and tumor growth, 
b) the direct targets of miRNAs in regulat-
ing tumorigenesis, and c) the functional 
relevant angiogenesis factors in arsenic- and 
miRNA-mediated carcinogenesis.
Materials and Methods
Cell culture and generation of stable cell lines. 
Human bronchial epithelial BEAS-2B cells 
[American Type Culture Collection (ATCC), 
Manassas, VA, USA] were cultured in DMEM 
(Dulbecco’s modified Eagle’s medium; 
Invitrogen, Carlsbad, CA, USA) supplemented 
with 10% fetal bovine serum (FBS). Human 
umbilical vein endothelial cells (HUVEC) 
(purchased from ATCC) were cultured in 
EBM-2 (endothelial basal medium-2) com-
plete medium. Arsenic-transformed BEAS-2B 
(AsT) cells (Carpenter et al. 2011) stably over-
expressing miR-199a or miR-control were 
generated by infecting BEAS-2B cells with 
lentivirus carry ing miR-199a-RFP or a nega-
tive control precursor (Applied Biosystems, 
Carlsbad, CA, USA), followed by selection 
with puromycin. To establish stable cell lines 
over expressing COX-2 (cyclooxygenase-2), 
293T cells were transfected with lentivirus 
carrying the COX-2 plasmid (GeneCopoeia, 
Rockville, MD, USA) or an empty vector 
to generate infectious virus. Then AsT cells 
were transduced with virus, followed by the 
puromycin selection. We also prepared PI3K 
(phosphatidyl inositide 3-kinase)–transformed 
chicken embryo fibroblast cells as was 
previously described (Chang et al. 1997; Jiang 
et al. 2000).
Animal experiment. Female CrTac:NCr-
Foxn1nu mice (8 weeks of age) were purchased 
from Taconic (Hudson, NY, USA), and main-
tained in pathogen-free conditions. Animals 
were housed in sterilized cages (5 mice/cage) 
with hardwood chip bedding. Standardized 
commercial diets were provided, and steril-
ized water was available at all times. The 
average weight of animals on arrival was 
20 ± 2 g (mean ± SD). A total of 2 × 106 
AsT/miR-cont cells or AsT/miR-199a cells 
(AsT cells stably over expressing miR-control 
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Background: Environmental and occupational exposure to arsenic is a major public health 
 concern. Although it has been identified as a human carcinogen, the molecular mechanism 
 underlying the arsenic-induced carcinogenesis is not well understood.
oBjectives: We aimed to determine the role and mechanisms of miRNAs in arsenic-induced tumor 
angiogenesis and tumor growth.
Methods: We utilized an in vitro model in which human lung epithelial BEAS-2B cells were trans-
formed through long-term exposure to arsenic. A human xenograft tumor model was established 
to assess tumor angiogenesis and tumor growth in vivo. Tube formation assay and chorio allantoic 
membranes assay were used to assess tumor angiogenesis.
results: We found that miR-199a-5p expression levels were more than 100-fold lower in arsenic-
transformed cells than parental cells. Re-expression of miR-199a-5p impaired arsenic-induced 
angiogenesis and tumor growth through its direct targets HIF-1α and COX-2. We further showed 
that arsenic induced COX-2 expression through HIF-1 regulation at the transcriptional level. In 
addition, we demonstrated that reactive oxygen species are an upstream event of miR-199a-5p/ 
HIF-1α/COX-2 pathway in arsenic-induced carcinogenesis.
conclusion: The findings establish critical roles of miR-199a-5p and its downstream targets 
HIF-1/COX-2 in arsenic-induced tumor growth and angiogenesis.
citation: He J, Wang M, Jiang Y, Chen Q, Xu S, Xu Q, Jiang BH, Liu LZ. 2014. Chronic arsenic 
exposure and angiogenesis in human bronchial epithelial cells via the ROS/miR-199a-5p/HIF-1α/
COX-2 Pathway. Environ Health Perspect 122:255–261; http://dx.doi.org/10.1289/ehp.1307545
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or miR-199a, respectively) in 80 μL were 
injected subcutaneously into the flanks of nude 
(nu/nu) mice (n = 10/group). The animals used 
in research were treated humanely accord-
ing to the Institutional Animal Care and Use 
Committee of Thomas Jefferson University. 
The mice were euthanized by decapitation 
6 weeks after injection. Tumor tissues were 
removed and weighed. Parts of tissues were 
paraffin-embedded, and other parts were snap-
frozen in liquid nitrogen and stored at –80°C 
for immunohistochemical analysis.
Reagents and antibodies. Sodium arsenic, 
catalase, and H2O2 were purchased from 
Sigma-Aldrich (St. Louis, MO, USA). Small 
interfering RNA (siRNA) Smartpools (pools 
of four individual siRNAs) against COX-2, 
HIF-1α (hypoxia inducible factor 1, alpha), 
and a scrambled control were purchased 
from Dharmacon (Lafayette, CO, USA). 
COX-2 antibody was from Cell Signaling 
Technology (Beverly, MA, USA). CD31 
(platelet/ endothelial cell adhesion molecule 1) 
antibody for analyzing paraffin-embedded 
tissues was from Santa Cruz Biotechnology 
(Santa Cruz, CA, USA) and for analyzing 
frozen tissues, from BD Pharmingen (San 
Jose, CA, USA). HIF-1α antibody was from 
BD Biosciences (Franklin Lakes, NJ, USA), 
and α-SMA (smooth muscle α-actin) anti-
body was obtained from Abcam (Cambridge, 
MA, USA). Primary antibodies used for 
Western analysis were diluted 1:1,000 in 5% 
bovine serum albumin as a working con-
centration and were incubated on a shaker 
overnight at 4°C.
RT-qPCR analysis. Total RNAs were 
extracted using Trizol (Life Technologies, 
Carlsbad, CA, USA). The synthesis of cDNA 
was performed using oligo (dT)18 primers 
and M-MLV (Moloney Murine Leukemia 
Virus) reverse transcriptase (Promega, 
Madison, WI, USA). The amplification 
was performed by polymerase chain reac-
tion (PCR). SYBR-green reverse transcrip-
tion PCR (RT-qPCR) was performed to 
detect COX-2 and GADPH (glyceraldehyde-
3-phosphate dehydrogenase) mRNA levels 
using the Power SYBR Green PCR Master 
Mix Kit (Applied Biosystems). Taqman 
RT-qPCR was performed to detect miRNA 
expression levels using the Taqman miRNA 
Reverse Transcription kit and Taqman uni-
versal PCR Master Mix (Applied Biosystems). 
The sequences of primer used for SYBR-green 
RT-qPCR were as follows:
•	COX-2 forward: 5´-TCAGC CAT ACAGC 
AAA TCCT T-3´
•	C O X - 2  r e v e r s e :  5 ´ - C T G C  A C T G 
TGTT AGTG G-3´
•	GAPDH forward: 5´-ATGG GTGT GAAC 
CATGA GAAG TATG -3´
•	G A D P H  r e v e r s e :  5 ´ G G T G  C A G G 
AGGC ATTG CT-3´.
Immunohistochemistry and immuno-
fluorescence. Paraffin-embedded tissue sections 
and frozen tissue sections were prepared by 
routine methods (Fero Lab, Fred Hutchinson 
Cancer Research Center 2011). For immuno-
histochemistry, the Dako Envision two-step 
method of immunohistochemistry was used 
to stain CD31 (1:100 dilution) and α-SMA 
(1:150 dilution) in xenograft tumor tissues as 
described previously (He et al. 2012a). Tissue 
sections were incubated with primary anti-
bodies in a humid chamber overnight at 4°C. 
The microvessel density reflected by CD31-
positive staining was counted in three different 
fields per section. For immuno fluorescence 
staining, frozen sections were incubated with 
primary antibodies overnight. Goat anti-
rabbit or anti-mouse IgG conjugated with 
fluorescein isothiocyanate or Texas Red (both 
from Santa Cruz Biotechnology) (1:200 dilu-
tion) were used as secon dary antibodies and 
 incubated for 2 hr at room temperature. Slides 
were mounted with anti-fade DAPI reagent 
(Invitrogen, Grand Island, NY, USA).
Chromatin immunoprecipation (ChIP)–
quantitative PCR (qPCR). ChIP-qPCR was 
performed using the EpiTect ChIP OneDay 
Kit (QIAGEN, Valencia, CA, USA) accord-
ing to the manufacturer’s instructions. 
HIF-1α antibody (Abcam) was used to pull 
down the protein–chromatin complexes. 
Rabbit IgG was used as a negative control. 
The immunoprecipated DNA was quanti-
fied using SYBR Green qPCR (Applied 
Biosystems). All results were normalized to 
1% input value of the same sample. COX-2 
primers flanking the hypoxia-response ele-
ments (HRE) for SYBR Green qPCR were 
as follows: 
•	Forward: 5´-TATA CAGC CTAT TAAG 
CGTC GTCA -3´
•	Reverse: 5´-CGTG TCTG GTCT GTAC 
GTCT TAG-3´.
Prostaglandin E2 (PGE2) ELISA. Cells 
were plated at 0.1 × 106 cells/well of a 
24-well plate and allowed to recover over-
night. The following day, the media were 
replaced with fresh media, and then the cells 
were cultured in normoxia or hypoxia (1% 
O2) for 24 hr. The conditioned media were 
then collected and cleared of cellular debris 
by centrifugation at 2,000 rpm for 2 min. 
PGE2 concentrations were determined using 
the Prostaglandin E2 EIA Kit–Monoclonal 
ELISA kit (no. 514010; Cayman Chemical, 
Ann Arbor, MI, USA) according to the man-
ufacturer’s instructions.
miRNA luciferase reporter constructs and 
luciferase activity assay. The 3´UTR-luciferase 
reporter constructs containing the 3´UTR 
regions of COX-2 with wild-type and mutant 
binding sites of miR-199a were amplified 
using the PCR method (GoTaq® G2 Flexi 
DNA Polymerase; Promega) according to the 
manufacturer’s instructions. The PCR prod-
ucts were cloned into the pMiR-luc luciferase 
reporter vector (Ambion, Grand Island, NY, 
USA). The mutant 3´UTR constructs were 
made by introducing four point mutations 
into the putative seed regions of COX-2. All 
the constructs containing 3´UTR inserts were 
sequenced and verified. The lucifer ase activity 
assay was performed as previously described 
(He et al. 2013a).
Site-directed mutagenesis. The human 
full-length COX-2 reporter used was a gen-
erous gift from J. Li (Harvard University, 
Boston, MA, USA) (Wu et al. 2006). To gen-
erate the HRE-mutant COX-2 reporter, we 
performed site-directed mutagenesis on the 
wild-type COX-2 reporter at the potential 
HIF-1α binding sites with 3 base pair sub-
stitutions as previously described (Jiang et al. 
1996). The mutant COX-2 reporter construct 
was validated by DNA sequencing.
Tube formation assay. HUVEC were 
cultured in EBM-2 complete medium, and 
switched to EBM-2 basal medium containing 
0.2% FBS for 24 hr before performing the 
tube formation assay. The conditioned media 
were prepared from different cells by replacing 
normal culture medium with serum-reduced 
medium (1% FBS). After culture for 24 hr, 
the serum-reduced media were collected and 
stored at –20°C for later use. The HUVEC 
were trypsinized, counted, and resuspended in 
EBM-2 basic medium; then they were mixed 
with an equal volume of the conditioned 
medium and seeded on Matrigel-pretreated 
96-well plates at 2 × 104 cells/well. After cul-
ture for 6-12 hr, tube formation was observed 
under a light microscope and photographed. 
The total lengths of the tubes in each well were 
measured using CellSens Standard software 
(Olympus; Hamburg, Germany).
The chorio allantoic membranes (CAM) 
assay. White Leghorn fertilized chicken eggs 
(Charles River, Malvern, PA, USA) were incu-
bated at 37°C under constant humidity. Cells 
were transfected with miRNA precursors, or 
treated as specifically indicated in the figure 
legends. After transfection for 12 hr, the cells 
were trypsinized, counted, and resuspended in 
the serum-free medium. The cell suspensions 
were mixed with Matrigel at a 1:1 ratio, and 
implanted onto the CAM of chicken eggs on 
day-9 embryos. Tumor angiogenesis responses 
were analyzed 5 days after the implantation. 
The tumor/Matrigel plugs were trimmed off 
the CAM and photographed. The number 
of blood vessels as the index of angio genesis 
was analyzed by counting the branches of 
blood vessels in three representative areas 
(each 1.0 mm2) by two observers in a double 
blind manner.
miRNA transfection. Cells were cul-
tured in 6-well plates to reach a 60% con-
fluency, and transfected using miR-199a or a 
miR-199a-5p in arsenic-induced tumor angiogenesis
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negative-control precursor (both from Applied 
Biosystems) at 30 nM using Lipofectamine 
RNAiMAX reagent (Invitrogen, Grand Island, 
NY, USA) according to the manufacturer’s 
instructions. Total proteins and RNAs were 
prepared from the cells 60–70 hr after the 
transfection, followed by Western blotting or 
RT-PCR analysis.
Hypoxia treatment. A hypoxia incuba-
tor chamber (Stemcell, Vancouver, British 
Columbia, Canada) was used to generate the 
hypoxia environment for cell culture. Cells 
were cultured in hypoxia conditions (1% O2) 
for 24 hr at 37°C.
Reactive oxygen species (ROS) study. Cells 
were treated with ROS scavenger catalase 
(1,500 U) or with H2O2 (50 μM) for 12 hr. 
Then cells were harvested, and total proteins 
were extracted for Western blotting analysis.
Statistical analysis. All the results were 
obtained from at least three independent 
experiments. Results are presented as 
mean ± SE and were analyzed by Student’s 
t-test or one-way analyis of variance 
(ANOVA). All results were analyzed by SPSS 
for Windows, version 11.5 (IBM, Chicago, 
IL, USA). Differences were considered 
significant with p < 0.05.
Results
miR-199a-5p is down-regulated in AsT 
cells. In order to investigate the mechanism 
of arsenic-induced carcinogenesis, we previ-
ously established an in vitro model by trans-
forming immortalized human lung epithelial 
BEAS-2B cells via chronic exposure to 1 μM 
sodium arsenic for 26 weeks (Carpenter et al. 
2011). BEAS-2B cells cultured in arsenic-
free medium served as a passage- matched 
control. We performed miRNA micro array 
analysis to compare the miRNA profiles 
between parental cells (BEAS-2B) and AsT 
cells. We found that miR-199a (referred to 
miR-199a-5p) was the most down- regulated 
miRNA among the list of miRNAs exam-
ined (data not shown). We further validated 
the result by performing Taqman RT-qPCR 
analysis. As shown in Figure 1A, miR-199a 
was 100-fold lower in AsT cells, indicating a 
major change of miRNA abundance in cell 
malignant trans formation (He et al. 2013b). 
To investi gate the relationship between 
arsenic treatment and miR-199a expres-
sion, we treated BEAS-2B cells with sodium 
arsenic at the doses of 0.5 μM, 1 μM, and 
2 μM for 24 hr. miR-199a expression levels 
were significantly decreased by arsenic treat-
ment at the dose of ≥ 1 μM (Figure 1B). To 
determine whether cell transformation affects 
miR-199a expression, we tested two differ-
ent types of cell lines transformed by onco-
genes: the AsT cells and PI3K–transformed 
chicken embryo fibroblast cells described 
above. miR-199a levels were decreased in 
transformed cells compared with the parental 
control cells, but the difference was not statis-
tically significant (see Supplemental Material, 
Figure S1). We also used newly transformed 
immortalized RE3K rat kidney cells [by N-Ras 
(neuro blastoma Ras)] (Kolligs et al. 1999) 
(see Supplemental Material, Figure S2A). 
We found that miR-199a expression levels 
in N-Ras–transformed cells were 1.9-fold 
lower compared with the control cells (see 
Supplemental Material, Figure S2B), indi-
cating that transformation and/or oncogenes 
may decrease miR-199a expression. However, 
given that miR-199a expression levels were 
Figure 1. miR-199a is down-regulated in AsT cells. (A) miR-199a expression levels were determined by 
Taqman RT-qPCR in AsT cells and BEAS-2B (B2B) cells. (B) B2B cells were treated with sodium arsenic 
at different concentrations for 24 hr. miR-199a expression levels were determined by RT-qPCR. Data are 
presented as mean ± SE and analyzed by Student’s t-test. 
*p < 0.05, compared with control cells.
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Figure 2. miR-199a inhibits arsenic-induced angiogenesis. (A) HUVEC cells were cultured in serum-
free medium overnight and resuspended in basic EBM-2 medium. Data represent mean ± SE from six 
replicates from each treatment and were analyzed by one-way ANOVA. Bar = 500 μM. (B) Weight of 
xenograft tumors from nude mice was measured 6 weeks after cell injection. Data represent mean ± SE 
(n = 10/group). (C) Paraffin-embedded tumor tissue sections from both groups were used for immuno-
histochemical staining using antibodies against CD31. Top: representative sections (magnification: 160×; 
bar = 50 μM). Bottom: quantification of microvessel density (MVD) indicated by CD31 staining in tumor 
sections. Data represent mean ± SE from five different tumor sections from each group. (D) Frozen tissue 
sections were used for immunofluorescence staining (magnification: 200×; bar = 50 μM). (E) Paraffin-
embedded tumor tissue sections were used for immunohistochemical staining using antibodies 
against α-SMA. Representative sections are shown. Arrow indicates mural cells (magnification: 320×; 
bar = 50 μM).
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more than 100-fold lower in AsT cells, we 
reason that arsenic plays a major role in the 
suppression of miR-199a expression.
miR-199a inhibits arsenic-induced angio-
genesis in vitro and in vivo. Our earlier study 
(He et al. 2013a) showed that miR-199a pro-
cesses an anti-angiogenic property in ovarian 
cancer cells. We then investigated the func-
tional effect of miR-199a in arsenic-induced 
angiogenesis by performing a tube forma-
tion assay in vitro. As shown in Figure 2A, 
tube formation was strongly induced when 
cultured in conditioned medium prepared 
from AsT cells as compared with its paren-
tal control BEAS-2B cells. Transient trans-
fection of miR-199a in AsT cells decreased 
tube formation by 40%. We next investi-
gated the angiogenic effect of miR-199a 
in vivo. First, we established AsT cells sta-
bly expressing miR-199a by transducing 
lentivirus-carrying miR-199a-RFP. Then we 
generated xenograft tumors by injecting the 
stable cells AsT/miR-cont and AsT/miR-199a 
sub cutaneously in nude mice and allowed 
tumors to grow for 6 weeks. Overexpression 
of miR-199a decreased the tumor weight by 
50% as compared with negative control cells 
(Figure 2B). The number of micro vessels 
indicated by the endothelial marker CD31 
staining in miR-199a–over expressing tumors 
was significantly lower than in the control 
(Figure 2C). As in normal blood vessels, 
tumor vessels consist of endothelial cells, 
mural cells (pericytes and smooth muscle 
cells), and basement membrane (Baluk 
et al. 2003). The expression of α-SMA was 
restricted to vascular smooth muscle cells 
and co-localized with CD31 (Figure 2D). 
Interestingly, we noticed that blood vessels 
from AsT/miR-199a tumors had many more 
mural cells reflected by α-SMA immuno-
reactivities than AsT/miR-cont tumors, 
suggesting that miR-199a decreases arsenic-
induced tumor angio genesis but promotes 
blood vessel maturation (Figure 2E).
miR-199a directly targets both HIF-1α 
and COX-2. HIF-1 is one of the major 
pro-angiogenic factors through inducing 
transcriptional activation of vascular endo-
thelial growth factor (VEGF) (Semenza 
2000). Another potent angiogenic activator 
for tumor angiogenesis is COX-2, which is 
a rate-limiting enzyme in the conversion of 
arachadonic acid precursors in the cell mem-
brane into PGE2 (Xue and Shah 2013). 
COX-2 and HIF-1α expression are fre-
quently regulated by similar stimuli and con-
trol similar processes within the cells (Gately 
2000; Liu et al. 1999). In the present study, 
we observed that basal levels of HIF-1α 
and COX-2 under normoxia were mark-
edly up-regulated in AsT cells (Figure 3A). 
Rane et al. (2009) reported that miR-199a 
directly targets HIF-1α in cardiac myocytes. 
Indeed, overexpression of miR-199a in AsT 
suppressed HIF-1α expression (Figure 3B). 
Interestingly, we noticed that miR-199a 
was also capable of down-regulating COX-2 
expression. To explore whether COX-2 can 
be directly targeted by miR-199a, we used 
the “target search” process to predict pos-
sible binding sites and free minimal energy 
of bindings and found that COX-2 is a puta-
tive target of miR-199a with two potential 
binding regions. COX-2 3´UTR luciferase 
reporters containing two putative miR-199a 
binding sites were constructed to validate 
the direct binding between COX-2 mRNA 
3´UTR and miR-199a. Co-transfection of 
miR-199a precursor with wild-type reporter 
constructs containing binding sites (COX-2 
3´UTR 311/320) greatly decreased the lucif-
erase activities in BEAS-2B cells, whereas co-
transfection with the corresponding reporter 
containing point mutant at putative miR-
199a binding sites did not affect the luciferase 
activities (Figure 3C). The luciferase activ-
ity in reporters containing putative binding 
sites in COX-2 3´UTR from 2021 to 2029 
was not affected by miR-199a, which sug-
gests that this computation-predicted site 
is not functionally targeted by miR-199a 
(Figure 3D). Consistently, the expression 
levels of COX-2 in xenograft tumors were 
generally lower in AsT/miR-199a groups than 
those in AsT/miR-cont groups (Figure 3E). 
These findings demonstrate that COX-2 is a 
novel direct target of miR-199a.
HIF-1α directly regulates COX-2 at the 
transcriptional level. We previously found 
that HIF-1α can be strongly induced by acute 
arsenic treatment in prostate cancer cells 
under normoxia condition (Gao et al. 2004). 
In this study, we observed that both HIF-1α 
and COX-2 expression levels were dramati-
cally up-regulated in AsT cells. We specu-
late whether there is an interaction between 
HIF-1α and COX-2 in this context. The 
COX-2 promoter contains several HREs, one 
of which we predicted to be functional (Jiang 
et al. 2009). In the present study, we first 
investigated whether HIF-1α is required for 
arsenic-induced COX-2 expression. COX-2 
mRNA and protein levels in BEAS-2B cells 
were up-regulated under the hypoxia con-
dition, whereas knockdown of HIF-1α by 
specific siRNA almost completely reversed 
the induction (Figures 4A-B). This indicates 
Figure 3. miR-199a directly targets both HIF-1α and COX-2. (A) Total proteins prepared from AsT cells and 
BEAS-2B (B2B) cells were used to determine protein levels of COX and HIF-1α by Western blotting analy-
sis. (B) AsT cells were transiently transfected with 25-nM miR-cont or miR-199a precursors for 72 hr, fol-
lowed by Western blotting analysis. (C, D) Sequence alignment of human miR-199a sequence with 3´ UTR 
region of COX-2. Data are presented as mean ± SE and analyzed by Student’s t-test. (E) COX-2 protein lev-
els in tumor tissues (n = 10/group) were determined by Western blotting analysis. Representative samples 
are shown.
*p < 0.05, compared with control cells.
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that hypoxia stimulates COX-2 expression 
via HIF-1α. We further measured the con-
centration of COX-2 product, PGE2, with 
the same treatments. Both BEAS-2B cells 
and AsT cells produced more PGE2 under 
hypoxia. Conversely, knockdown of HIF-1α 
decreased PGE2 concentration with hypoxic 
treatment (Figure 4C). To determine if there 
is a direct interaction between HIF-1α and 
COX-2 promoter, we performed the ChIP 
assay. BEAS-2B cells were cultured in hypoxic 
chamber for 24h and were subjected to 
ChIP assay. As shown in Figure 4D, anti-
body against HIF-1α was able to pull down 
COX-2 promoter suggesting the association 
between HIF-1α and COX-2 gene. The ear-
lier findings in our group predicted that one 
of HRE (-576/-584) in the COX-2 promoter 
would be functional (Jiang et al. 2009). We 
validated the binding sites by construct-
ing COX-2 promoter luciferase reporters 
with wild-type or mutant HRE. As shown 
in Figure 4E, hypoxia stimulated COX-2 
transcriptional activity measured by luciferase 
activity in BEAS-2B cells transfected with 
wild-type reporter. Conversely, BEAS-2B 
cells transfected with mutant reporter weren’t 
affected by hypoxia. Furthermore, co-trans-
fection of HIF-1α with the wild-type reporter 
similarly promoted COX-2 transcrip-
tion while co-transfection with the mutant 
reporter did not affect the luciferase activities 
(Figure 4F). Collectively, these data support 
that HIF-1α directly regulates COX-2 at the 
transcriptional level.
miR-199a inhibits arsenic-induced 
angiogenesis via COX-2 expression. To deter-
mine the role of COX-2 in arsenic-induced 
angiogenesis, we knocked down COX-2 to 
evaluate the angiogenesis response using 
the CAM assay (Figure 5A). We observed a 
dramatic decrease of angiogenic potential in 
COX-2 knockdown cells (Figure 5B). To test 
whether the overexpression of COX-2 with-
out miR-199a binding sites is able to reverse 
miR-199a–inhibited angiogensis in AsT cells, 
we established stable AsT cells over expressing 
COX2 by transducing lentivirus carrying 
COX-2 cDNA without 3´UTR region. We 
observed that forced expression of COX-2 
completely reversed the inhibitory effect of 
miR-199a in angiogenesis (Figure 5C). Taken 
together, these results suggest that miR-199a 
inhibits arsenic-induced angiogenesis by 
directly targeting COX-2 expression.
ROS induce COX-2 pathway by sup-
pressing miR-199a in AsT cells. Induction 
of ROS in cells is closely related with heavy 
metal exposure including arsenic, chromium, 
and cadmium (Azad et al. 2010; Huang 
et al. 2004; Wang et al. 2012). We previ-
ously observed that AsT cells produced higher 
ROS (Carpenter et al. 2011). In addition, 
our earlier findings indicate that miR-199a 
is a ROS responsive miRNA in which ROS 
inhibit miR-199a expression through increas-
ing the promoter methylation of miR-199a 
gene by DNA methyltransferase 1 (He et al. 
2012b). In this study, we found that ROS 
treatment increased COX-2 expression, 
whereas the ROS scavenger catalase decreased 
COX-2 expression (Figure 6A). To investi-
gate whether ROS are upstream signals for 
inhibiting miR-199a expression, we treated 
AsT cells stably over expressing miR-199a 
and AsT control cells with H2O2. We found 
that H2O2–induced COX-2 expression in 
AsT/miR-cont cells, but no induction was 
observed in AsT/miR-199a cells (Figure 6B).
Discussion
The strong links between the aberration of 
miRNAs profiles and carcinogenesis, cancer 
development, prognosis and chemo resistance 
have been confirmed by a plethora of bench 
and clinical studies (reviewed by Iorio and 
Croce 2012). In this study, we identified that 
exposure to arsenic induced the suppression of 
miR-199a expression, which led to increased 
angiogenesis responses and tumor growth.
The process of angiogenesis normally 
occurs in the embryo, placenta, and during 
menstrual cycle and wound-healing (Patella 
and Rainaldi 2012). However, under patho-
logical situations such as cancer, the same 
angiogenic signaling pathways in tumors 
are induced in order to obtain the sufficient 
blood supply for tumor growth. A number of 
miRNAs have been reported to be involved 
in blood vessel development and angio-
genesis by directly or indirectly regulating 
pro-angiogenic factors or anti-angiogenic fac-
tors (Hua et al. 2006; Poliseno et al. 2006; 
Urbich et al. 2008). Our previous study (He 
et al. 2013a) showed that miR-199a inhibits 
tumor angiogenesis by targeting ERBB2 and 
ERBB3 thus suppressing their downstream 
VEGF in ovarian cancer cells. In the context 
of arsenic-induced transformation, miR-199a 
showed strong anti-angiogenic properties not 
Figure 4. HIF-1α directly regulates COX-2 expression at the transcriptional level. (A,B) BEAS-2B (B2B) 
cells were incubated under normoxic or hypoxic condition (1% oxygen) for 24 hr or transfected with 50 nM 
of a siRNA scramble control or a siRNA SMARTpool against HIF-1α for 72 hr as indicated. The mRNA lev-
els (A) and protein levels (B) of COX-2 were determined by SYBR-green RT-qPCR or Western blotting anal-
ysis, respectively. (C) The concentrations of PGE2 in B2B cells and AsT cells were determined by ELISA. 
(D) B2B cells were cultured under hypoxia for 24 hr and were subjected to the ChIP assay using antibodies 
against IgG or HIF-1α. The antibody-promoter binding signals were analyzed by SYBR-qPCR. (E) B2B cells 
were co-transfected with COX-2 luciferase reporters with wild-type or mutant HIF-1α binding sites and 
β-gal plasmid. Cells were incubated under normoxia or hypoxia 24 hr before harvest. (F) B2B cells were 
co-transfected with COX-2 wild-type or mutant reporters, HIF-1α plasmid or vector, and β-gal plasmid. 
Luciferase activity assay was performed 60 hr after transfection. Data are presented as mean ± SE of 
three independent experiments and analyzed by one-way ANOVA. 
*p < 0.05, compared with control. #p < 0.05, compared with scrambled control. 
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only by directly targeting HIF-1α but also 
another proangiogenic factor COX-2, which 
highlights the important role of miR-199a in 
angiogenesis. Tumor vessels are leaky, imma-
ture, or morphologically abnormal because of 
the absent or incomplete basement membrane 
and mural cells (pericytes and smooth muscle 
cells). Failure of tumor vessels to recruit a 
normal coat of mural cells may contribute to 
the abnormality of vessels (Abramsson et al. 
2002). Berthod et al. (2012) showed that 
α-SMA expressing cells were present around 
capillaries and can thus act as a pericyte 
marker. Interestingly, we found that miR-
199a can not only reduce the total number 
of microvessels in tumors but also promote 
vascular maturation as indicated by the higher 
α-SMA staining.
HIF-1α signaling plays a critical role in 
tumor metastasis, invasion, metabolism, and, 
especially, angiogenesis (Covello and Simon 
2004; Lum et al. 2007). We found that the 
baseline of HIF-1α expression, which is 
oxygen independent, was dramatically up-
regulated in arsenic- transformed cells. The 
under lying mechanism might be the activation 
of thymoma viral oncogene (AKT), mitogen-
activated protein kinase (ERK), mechanistic 
target of rapamycin (serine/threonine kinase; 
mTOR), and ribosomal protein S6 kinase, 
polypeptide 1 (p70S6K1) genes, as suggested 
by our earlier results (Carpenter et al. 2011). 
A recent study reported that overexpression 
of miR-199a inhibited the hypoxia-induced 
cell proliferation in non-small cell lung 
cancer by suppressing HIF-1α (Ding et al. 
2013). Oltipraz, a cancer chemopreventive 
agent, has anti-angiogenic property mediated 
by miR-199a induction and HIF-1α inhi-
bition (Kang et al. 2012). Consistent with 
the report of Kang et al. (2012), our results 
show that miR-199a suppression by arsenic 
exposure releases its direct target inhibition of 
HIF-1α. More importantly, we also validated 
that COX-2 is a novel target of miR-199a 
and is functional in AsT cells. The COX-2 
expression was almost undetectable in paren-
tal BEAS-2B cells, but it was pronouncedly 
expressed after chronic arsenic exposure. Our 
functional study revealed that COX-2 plays 
an important role in arsenic-induced angio-
genesis, which can be impaired by miR-199a 
overexpression. Furthermore, consistent with 
other studies (Csiki et al. 2006; Kaidi et al. 
2006), both protein-DNA binding assay 
and luciferase reporter assay confirmed that 
HIF-1α directly regulates COX-2 expression 
in parental BEAS-2B cells. This result along 
with data that PGE2 can stimulate VEGF 
expression through the activation of HIF-1α 
(Greenhough et al. 2009) suggests a positive-
feedback between HIF-1α and COX-2 in 
arsenic-induced angiogenesis. The findings 
also indicate that miR-199a may have high 
therapeutic efficiency as a tumor suppressor by 
targeting both HIF-1α and COX-2. In addi-
tion, miR-199a-3p has also been reported to 
target COX-2 in human chondrocytes (Akhtar 
and Haqqi 2012). Because miR-199a-3p and 
miR-199a-5p (miR-199a) are derived from 
the same precursor, the expression levels of 
both miRNAs may be somewhat regulated 
Figure 6. Excessive ROS is an upstream signal of miR-199a/COX-2 pathway in AsT cells. (A) AsT cells were 
treated with catalase (1,500 U) or H2O2 (50 μM) for 12 hr, followed by Western blotting analysis. Bottom: 
quantification from three independent experiments using densitometry. (B) AsT cells stably expressing 
control or miR-199a were treated with H2O2 (50 μM) for 12 hr. COX-2 expression levels were determined by 
Western blotting analysis. Bottom: quantification from three independent experiments using densitometry. 
Student’s t-test was used to determine the difference. (C) Schematic diagram for proposed pathway.
*p < 0.05, compared with control. 
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Figure 5. miR-199a inhibits As-induced angiogenesis via COX-2. (A) AsT cells were transfected with 50 nM of a siRNA scramble control or smartpool siRNAs 
against COX-2 for 60 hr, followed by Western blotting analysis. (B) The cells were implanted onto the CAMs 24 hr after transfection (AsT cells were transfected 
with a siRNA control or a siRNAs against COX-2) to perform angiogenesis assay. Top: representative images from each group; bottom: relative angiogenesis 
responses (mean ± SE; n = 8/group). (C) AsT, AsT/vector, or AsT/COX-2 cells were infected with miR-199a lentivirus for 24 hr. Then cells were used to perform 
angiogenesis assay. Top: representative images. Bottom: relative angiogenesis responses (mean ± SE; n = 8). One-way ANOVA was used to analyze the 
differences among various groups.
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by the same mechanism(s). Further investiga-
tion of the upstream molecules that may indi-
rectly modulate COX-2 expression via both 
 miRNAs in the future is of interest.
Overproduction of ROS is closely related 
to heavy metal–mediated carcinogenesis (Lee 
et al. 2012). Oxidative stress was reported 
as a mediator of arsenic-induced cell trans-
formation and carcinogenesis (Carpenter 
et al. 2011; Wang et al. 2012). In addition, 
ROS can activate HIF-1α and COX-2 in 
various contexts (Bonello et al. 2007; Chen 
et al. 2012). However, the mechanism under-
lying how ROS regulate HIF-1α and COX-2 
remains to be investigated. Here, we provide 
a link in which repression of miR-199a by 
arsenic-induced ROS activates HIF-1α and 
COX-2 expression.
We found similar miR-199a suppression 
and HIF-1α/COX-2 activation in Cr (VI)–
transformed cells (see Supplemental Material, 
Figure S3). Further investigation is needed 
to determine whether the same pathway is 
generally activated in other metal-induced 
cell transformation. 
Conculsions
The present study provides a new mecha-
nism of arsenic-induced tumor angiogenesis 
and tumor growth. Arsenic-induced ROS 
inhibit miR-199a expression via DNMT1-
mediated DNA methylation. The repression 
of miR-199a expression results in induction 
of HIF-1α and COX-2. In addition, the 
bidirec tional regulations between HIF-1α 
and COX-2 forming a positive feedback fur-
ther promote tumor angiogenesis and tumor 
growth (Figure 6C). Our findings may have 
clinical implication in targeted therapy for 
arsenic-induced lung cancer in the future.
RefeRences
Abramsson A, Berlin O, Papayan H, Paulin D, Shani M, 
Betsholtz C. 2002. Analysis of mural cell recruitment to 
tumor vessels. Circulation 105:112–117.
Akhtar N, Haqqi TM. 2012. MicroRNA-199a* regulates the 
expression of cyclooxygenase-2 in human chondrocytes. 
Ann Rheum Dis 71:1073–1080.
Azad N, Iyer A, Vallyathan V, Wang L, Castranova V, Stehlik C, 
et al. 2010. Role of oxidative/nitrosative stress-mediated 
Bcl-2 regulation in apoptosis and malignant transformation. 
Ann NY Acad Sci 1203:1–6.
Baluk P, Morikawa S, Haskell A, Mancuso M, McDonald DM. 
2003. Abnormalities of basement membrane on blood 
vessels and endothelial sprouts in tumors. Am J Pathol 
163:1801–1815.
Beezhold K, Liu J, Kan H, Meighan T, Castranova V, Shi X, 
et al. 2011. miR-190-mediated downregulation of PHLPP 
contributes to arsenic-induced Akt activation and carcino-
genesis. Toxicol Sci 123:411–420.
Berthod F, Symes J, Tremblay N, Medin JA, Auger FA. 2012. 
Spontaneous fibroblast-derived pericyte recruitment in 
a human tissue-engineered angiogenesis model in vitro. 
J Cell Physiol 227:2130–2137.
Boffetta P. 2004. Epidemiology of environmental and occupa-
tional cancer. Oncogene 23:6392–6403.
Bonello S, Zähringer C, BelAiba RS, Djordjevic T, Hess J, 
Michiels C, et al. 2007. Reactive oxygen species acti-
vate the HIF-1α promoter via a functional NFκB site. 
Arterioscler Thromb Vasc Biol 27:755–761.
Carpenter RL, Jiang Y, Jing Y, He J, Rojanasakul Y, Liu LZ, et al. 
2011. Arsenite induces cell transformation by reactive oxy-
gen species, AKT, ERK1/2, and p70S6K1. Biochem Biophys 
Res Commun 414:533–538.
Chang HW, Aoki M, Fruman D, Auger KR, Bellacosa A, 
Tsichlis PN, et al. 1997. Transformation of chicken cells 
by the gene encoding the catalytic subunit of PI 3-kinase. 
Science 276:1848–1850.
Chen CC, Cheng YY, Chen SC, Tuan YF, Chen YJ, Chen CY, et al. 
2012. Cyclooxygenase-2 expression is up-regulated by 
2-aminobiphenyl in a ROS and MAPK-dependent signaling 
pathway in a bladder cancer cell line. Chem Res Toxicol 
25:695–705.
Chen CL, Hsu LI, Chiou HY, Hsueh YM, Chen SY, Wu MM, 
et al. 2004. Ingested arsenic, cigarette smoking, and lung 
cancer risk: a follow-up study in arseniasis-endemic areas 
in Taiwan. JAMA 292:2984–2990.
Covello KL, Simon MC. 2004. HIFs, hypoxia, and vascular 
develop ment. Curr Top Dev Biol 62:37–54.
Csiki I, Yanagisawa K, Haruki N, Nadaf S, Morrow JD, 
Johnson DH, et al. 2006. Thioredoxin-1 modulates transcrip-
tion of cyclooxygenase-2 via hypoxia-inducible factor-1α in 
non-small cell lung cancer. Cancer Res 66:143–150.
D’Amico TA. 2004. Angiogenesis in non-small cell lung cancer. 
Semin Thorac Cardiovasc Surg 16:13–18.
Ding G, Huang G, Liu HD, Liang HX, Ni YF, Ding ZH, et al. 2013. 
MiR-199a suppresses the hypoxia-induced proliferation of 
non-small cell lung cancer cells through targeting HIF1α. 
Mol Cell Biochem 2013 384(1–2):173–180.
Fero Lab, Fred Hutchinson Cancer Research Center. 2011. 
Tissue Processing and Sectioning. Available: http://labs.
fhcrc.org/fero/Protocols/processing.html [accessed 
28 January 2014].
Gao N, Shen L, Zhang Z, Leonard SS, He H, Zhang XG, et al. 
2004. Arsenite induces HIF-1α and VEGF through PI3K, 
Akt and reactive oxygen species in DU145 human prostate 
carcinoma cells. Mol Cell Biochem 255:33–45.
Gately S. 2000. The contributions of cyclooxygenase-2 to tumor 
angiogenesis. Cancer Metastasis Rev 19:19–27.
Greenhough A, Smartt HJ, Moore AE, Roberts HR, Williams AC, 
Paraskeva C, et al. 2009. The COX-2/PGE2 pathway: key 
roles in the hallmarks of cancer and adaptation to the 
tumour microenvironment. Carcinogenesis 30:377–386.
He J, Jing Y, Li W, Qian X, Xu Q, Li FS, et al. 2013a. Roles and 
mechanism of miR-199a and miR-125b in tumor angio genesis. 
PLoS One 8:e56647; doi:10.1371/journal.pone.0056647.
He J, Qian X, Carpenter R, Xu Q, Wang L, Qi Y, et al. 2013b. 
Repression of miR-143 mediates Cr (VI)–induced tumor 
angiogenesis via IGF-IR/IRS1/ERK/IL-8 pathway. Toxicol 
Sci 134:26–38.
He J, Xu Q, Jing Y, Agani F, Qian X, Carpenter R, et al. 2012b. 
Reactive oxygen species regulate ERBB2 and ERBB3 
expression via miR-199a/125b and DNA methylation. 
EMBO Rep 13:1116–1122.
He J, Xu Q, Wang M, Li C, Qian X, Shi Z, et al. 2012a. Oral 
administration of apigenin inhibits metastasis through 
AKT/P70S6K1/MMP-9 pathway in orthotopic ovarian tumor 
model. Int J Mol Sci 13:7271–7282.
Hua Z, Lv Q, Ye W, Wong CK, Cai G, Gu D, et al. 2006. MiRNA-
directed regulation of VEGF and other angiogenic factors 
under hypoxia. PLoS One 1:e116; doi:10.1371/journal.
pone.0000116.
Huang C, Ke Q, Costa M, Shi X. 2004. Molecular mechanisms of 
arsenic carcinogenesis. Mol Cell Biochem 255:57–66.
Hubaux R, Becker-Santos DD, Enfield KS, Rowbotham D, 
Lam S, Lam WL, et al. 2013. Molecular features in arsenic-
induced lung tumors. Mol Cancer 12:20; doi:10.1186/1476-
4598-12-20.
Iorio MV, Croce CM. 2012. MicroRNA dysregulation in cancer: 
diagnostics, monitoring and therapeutics. A comprehensive 
review. EMBO Mol Med 4:143–159.
Jiang BH, Rue E, Wang GL, Roe R, Semenza GL. 1996. 
Dimerization, DNA binding, and transactivation proper ties 
of hypoxia-inducible factor 1. J Biol Chem 271:17771–17778.
Jiang BH, Zheng JZ, Aoki M, Vogt PK. 2000. Phosphatidylinositol 
3-kinase signaling mediates angiogenesis and expression 
of vascular endothelial growth factor in endothelial cells. 
Proc Natl Acad Sci USA 97:1749–1753.
Jiang Y, Cukic B, Adjeroh DA, Skinner HD, Lin J, Shen QJ, et al. 
2009. An algorithm for identifying novel targets of tran-
scription factor families: application to hypoxia-inducible 
factor 1 targets. Cancer Inform 7:75–89.
Kaidi A, Qualtrough D, Williams AC, Paraskeva C. 2006. Direct 
transcriptional up-regulation of cyclooxygenase-2 by 
hypoxia-inducible factor (HIF)-1 promotes colorectal tumor 
cell survival and enhances HIF-1 transcriptional activity 
during hypoxia. Cancer Res 66:6683–6691.
Kang SG, Lee WH, Lee YH, Lee YS, Kim SG. 2012. Hypoxia-
inducible factor-1α inhibition by a pyrrolopyrazine metab-
olite of oltipraz as a consequence of microRNAs 199a-5p 
and 20a induction. Carcinogenesis 33:661–669.
Kolligs FT, Hu G, Dang CV, Fearon ER. 1999. Neoplastic trans-
formation of RK3E by mutant β-catenin requires deregula-
tion of Tcf/Lef transcription but not activation of c-myc 
expression. Mol Cell Biol 19:5696–5706.
Lee JC, Son YO, Pratheeshkumar P, Shi X. 2012. Oxidative 
stress and metal carcinogenesis. Free Radic Biol Med 
53:742–757.
Liu XH, Kirschenbaum A, Yao S, Stearns ME, Holland JF, 
Claffey K, et al. 1999. Upregulation of vascular endothelial 
growth factor by cobalt chloride-simulated hypoxia is 
mediated by persistent induction of cyclooxygenase-2 
in a metastatic human prostate cancer cell line. Clin Exp 
Metastasis 17:687–694.
Lum JJ, Bui T, Gruber M, Gordan JD, DeBerardinis RJ, 
Covello KL, et al. 2007. The transcription factor HIF-1α 
plays a critical role in the growth factor-dependent regula-
tion of both aerobic and anaerobic glycolysis. Genes Dev 
21:1037–1049.
Patella F, Rainaldi G. 2012. MicroRNAs mediate metabolic 
stresses and angiogenesis. Cell Mol Life Sci 69:1049–1065.
Poliseno L, Tuccoli A, Mariani L, Evangelista M, Citti L, 
Woods K, et al. 2006. MicroRNAs modulate the angiogenic 
properties of HUVECs. Blood 108:3068–3071.
Rahman MM, Chowdhury UK, Mukherjee SC, Mondal BK, 
Paul K, Lodh D, et al. 2001. Chronic arsenic toxicity in 
Bangladesh and West Bengal, India—a review and com-
mentary. J Toxicol Clin Toxicol 39:683–700.
Rane S, He M, Sayed D, Vashistha H, Malhotra A, Sadoshima J, 
et  al. 2009. Downregulation of miR-199a derepresses 
hypoxia-inducible factor-1α and Sirtuin 1 and recapitu-
lates hypoxia preconditioning in cardiac myocytes. Circ 
Res 104:879–886.
Semenza GL. 2000. HIF-1: mediator of physiological and 
pathophysiological responses to hypoxia. J Appl Physiol 
88:1474–1480.
Urbich C, Kuehbacher A, Dimmeler S. 2008. Role of microRNAs 
in vascular diseases, inflammation, and angiogenesis. 
Cardiovasc Res 79:581–588.
U.S. Environmental Protection Agency. 2014. Drinking Water 
Contaminants. Available: http://water.epa.gov/drink/
contaminants/index.cfm#two [accessed 30 January 2014].
Wang X, Mandal AK, Saito H, Pulliam JF, Lee EY, Ke ZJ, et al. 
2012. Arsenic and chromium in drinking water promote 
tumorigenesis in a mouse colitis-associated colo rectal can-
cer model and the potential mechanism is ROS-mediated 
Wnt/β-catenin signaling pathway. Toxicol Appl Pharmacol 
262:11–21.
Wang Z, Zhao Y, Smith E, Goodall GJ, Drew PA, Brabletz T, 
et al. 2011. Reversal and prevention of arsenic-induced 
human bronchial epithelial cell malignant transformation 
by microRNA-200b. Toxicol Sci 121:110–122.
Wu G, Luo J, Rana JS, Laham R, Sellke FW, Li J. 2006. 
Involvement of COX-2 in VEGF-induced angiogenesis 
via P38 and JNK pathways in vascular endothelial cells. 
Cardiovasc Res 69:512–519.
Xue X, Shah YM. 2013. Hypoxia-inducible factor-2α is essential 
in activating the COX2/mPGES-1/PGE2 signaling axis in 
colon cancer. Carcinogenesis 34:163–169.
